Inhibikase Therapeutics shares owned by Armistice Capital
Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Armistice Capital
from 13F filings
Historical chart of Armistice Capital investment in Inhibikase Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Inhibikase Therapeutics held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Inhibikase Therapeutics by Armistice Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $815k | 627k | 1.30 |
| 2024-06-30 | $713k | 590k | 1.21 |
| 2023-09-30 | $259k | 186k | 1.39 |
| 2023-06-30 | $1.8M | 497k | 3.61 |